Eastern Nephrology Associates, PLLC

New Bern, North Carolina 28562

0 studies enrolling now · 6 studies all time

What they study most

Atrial Fibrillation, Cardiovascular Disease, Chronic Kidney Disease, Chronic Renal Failure, Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, End Stage Renal Disease, Endocrine System Diseases, Glomerulonephritis, Glomerulosclerosis, Focal Segmental, Kidney Diseases

Studies at this site

• REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo — Completed
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — Stopped early
• Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation — Completed
• Cardiovascular Inflammation Reduction Trial — Completed
• A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin — Completed